Tenn. Code Ann. § 63-1-401
This is the official text of Tenn. Code Ann. § 63-1-401, part of Tennessee’s Code Ann — part of the compiled statutory law of Tennessee, published by the state as "Code Ann." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Part definitions - Development of recommended treatment guidelines for prescribing opioids - Development of pain clinic guidelines - Study of co-prescription of naloxone with opioid - Review of guidelines - Notification of licensees
Official statutory text
(a) As used in this part: (1) "Commissioner" means the commissioner of health; (2) "Pain clinic guidelines" means systematically developed standards to assist healthcare providers and pain clinic certificate holders in making decisions concerning the appropriate medical care for chronic nonmalignant pain treatment, as defined in § 63-1-301 ; and (3) "Treatment guidelines" means systematically developed statements to assist healthcare providers in making patient decisions concerning appropriate medical care for specific clinical circumstances and settings. (b) By January 1, 2016, the commissioner shall develop recommended treatment guidelines for prescribing opioids that can be used by prescribers in this state as a guide for caring for patients. This subsection (b) shall not apply to veterinarians. (c) By January 1, 2017, the commissioner shall develop recommended pain clinic standards for the operation of a pain management clinic, as defined in § 63-1-301 , that can be used by certified pain clinics in this state as a guide for operating a pain clinic. This subsection (c) shall not apply to veterinarians. (d) By January 1, 2020, the commissioner shall: (1) Study instances when co-prescribing of naloxone with an opioid is beneficial and publish the results to each prescribing board that licenses healthcare professionals who can legally prescribe controlled substances and to the board of pharmacy; and (2) Include the findings in the treatment guidelines for prescribing opioids developed pursuant to subsection (b). (e) The commissioner shall review treatment guidelines and the pain clinic guidelines by September 30 of each year and shall cause these guidelines to be posted on the department's website. (f) The treatment guidelines shall be submitted to each prescribing board that licenses health professionals who can legally prescribe controlled substances and to the board of pharmacy. Each board shall be charged with reviewing the treatment guidelines and determining how the treatment guidelines should be used by that board's licensees. (g) The pain clinic guidelines shall be submitted to each board that licenses individuals eligible to hold a pain clinic certificate for review and concurrence. (h) Each board shall notify all of its licensees through routine bulletins or newsletters of the existence of the guidelines and standards. Amended by 2019 Tenn. Acts, ch. 327, s 1, eff. 5/8/2019. Amended by 2015 Tenn. Acts, ch. 475, s 6, eff. 7/1/2015. Added by 2013 Tenn. Acts, ch. 430, s 2, eff. 5/16/2013.
(a) As used in this part: (1) "Commissioner" means the commissioner of health; (2) "Pain clinic guidelines" means systematically developed standards to assist healthcare providers and pain clinic certificate holders in making decisions concerning the appropriate medical care for chronic nonmalignant pain treatment, as defined in § 63-1-301 ; and (3) "Treatment guidelines" means systematically developed statements to assist healthcare providers in making patient decisions concerning appropriate medical care for specific clinical circumstances and settings.
(1) "Commissioner" means the commissioner of health;
(2) "Pain clinic guidelines" means systematically developed standards to assist healthcare providers and pain clinic certificate holders in making decisions concerning the appropriate medical care for chronic nonmalignant pain treatment, as defined in § 63-1-301 ; and
(3) "Treatment guidelines" means systematically developed statements to assist healthcare providers in making patient decisions concerning appropriate medical care for specific clinical circumstances and settings.
(b) By January 1, 2016, the commissioner shall develop recommended treatment guidelines for prescribing opioids that can be used by prescribers in this state as a guide for caring for patients. This subsection (b) shall not apply to veterinarians.
tements to assist healthcare providers in making patient decisions concerning appropriate medical care for specific clinical circumstances and settings.
(b) By January 1, 2016, the commissioner shall develop recommended treatment guidelines for prescribing opioids that can be used by prescribers in this state as a guide for caring for patients. This subsection (b) shall not apply to veterinarians.
(c) By January 1, 2017, the commissioner shall develop recommended pain clinic standards for the operation of a pain management clinic, as defined in § 63-1-301 , that can be used by certified pain clinics in this state as a guide for operating a pain clinic. This subsection (c) shall not apply to veterinarians.
(d) By January 1, 2020, the commissioner shall: (1) Study instances when co-prescribing of naloxone with an opioid is beneficial and publish the results to each prescribing board that licenses healthcare professionals who can legally prescribe controlled substances and to the board of pharmacy; and (2) Include the findings in the treatment guidelines for prescribing opioids developed pursuant to subsection (b).
(1) Study instances when co-prescribing of naloxone with an opioid is beneficial and publish the results to each prescribing board that licenses healthcare professionals who can legally prescribe controlled substances and to the board of pharmacy; and
(2) Include the findings in the treatment guidelines for prescribing opioids developed pursuant to subsection (b).
(e) The commissioner shall review treatment guidelines and the pain clinic guidelines by September 30 of each year and shall cause these guidelines to be posted on the department's website.
(f) The treatment guidelines shall be submitted to each prescribing board that licenses health professionals who can legally prescribe controlled substances and to the board of pharmacy. Each board shall be charged with reviewing the treatment guidelines and determining how the treatment guidelines should be used by that board's licensees.
(g) The pain clinic guidelines shall be submitted to each board that licenses individuals eligible to hold a pain clinic certificate for review and concurrence.
(h) Each board shall notify all of its licensees through routine bulletins or newsletters of the existence of the guidelines and standards.
Amended by 2019 Tenn. Acts, ch. 327, s 1, eff. 5/8/2019.
Amended by 2015 Tenn. Acts, ch. 475, s 6, eff. 7/1/2015.
Added by 2013 Tenn. Acts, ch. 430, s 2, eff. 5/16/2013.
(a) As used in this part: (1) "Commissioner" means the commissioner of health; (2) "Pain clinic guidelines" means systematically developed standards to assist healthcare providers and pain clinic certificate holders in making decisions concerning the appropriate medical care for chronic nonmalignant pain treatment, as defined in § 63-1-301 ; and (3) "Treatment guidelines" means systematically developed statements to assist healthcare providers in making patient decisions concerning appropriate medical care for specific clinical circumstances and settings.
(1) "Commissioner" means the commissioner of health;
(2) "Pain clinic guidelines" means systematically developed standards to assist healthcare providers and pain clinic certificate holders in making decisions concerning the appropriate medical care for chronic nonmalignant pain treatment, as defined in § 63-1-301 ; and
(3) "Treatment guidelines" means systematically developed statements to assist healthcare providers in making patient decisions concerning appropriate medical care for specific clinical circumstances and settings.
(b) By January 1, 2016, the commissioner shall develop recommended treatment guidelines for prescribing opioids that can be used by prescribers in this state as a guide for caring for patients. This subsection (b) shall not apply to veterinarians.
tements to assist healthcare providers in making patient decisions concerning appropriate medical care for specific clinical circumstances and settings.
(b) By January 1, 2016, the commissioner shall develop recommended treatment guidelines for prescribing opioids that can be used by prescribers in this state as a guide for caring for patients. This subsection (b) shall not apply to veterinarians.
(c) By January 1, 2017, the commissioner shall develop recommended pain clinic standards for the operation of a pain management clinic, as defined in § 63-1-301 , that can be used by certified pain clinics in this state as a guide for operating a pain clinic. This subsection (c) shall not apply to veterinarians.
(d) By January 1, 2020, the commissioner shall: (1) Study instances when co-prescribing of naloxone with an opioid is beneficial and publish the results to each prescribing board that licenses healthcare professionals who can legally prescribe controlled substances and to the board of pharmacy; and (2) Include the findings in the treatment guidelines for prescribing opioids developed pursuant to subsection (b).
(1) Study instances when co-prescribing of naloxone with an opioid is beneficial and publish the results to each prescribing board that licenses healthcare professionals who can legally prescribe controlled substances and to the board of pharmacy; and
(2) Include the findings in the treatment guidelines for prescribing opioids developed pursuant to subsection (b).
(e) The commissioner shall review treatment guidelines and the pain clinic guidelines by September 30 of each year and shall cause these guidelines to be posted on the department's website.
(f) The treatment guidelines shall be submitted to each prescribing board that licenses health professionals who can legally prescribe controlled substances and to the board of pharmacy. Each board shall be charged with reviewing the treatment guidelines and determining how the treatment guidelines should be used by that board's licensees.
(g) The pain clinic guidelines shall be submitted to each board that licenses individuals eligible to hold a pain clinic certificate for review and concurrence.
(h) Each board shall notify all of its licensees through routine bulletins or newsletters of the existence of the guidelines and standards.
Amended by 2019 Tenn. Acts, ch. 327, s 1, eff. 5/8/2019.
Amended by 2015 Tenn. Acts, ch. 475, s 6, eff. 7/1/2015.
Added by 2013 Tenn. Acts, ch. 430, s 2, eff. 5/16/2013.
Status: in_force
Need a lawyer in Tennessee?
Find a Tennessee lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.